Back

Precision medicine in long QT syndrome

19 March 2018 (11:45 - 12:07)
Organised by:
Congress Presentation Part of: Implication of basic insights for management of channelopathies Myocardial Disease EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Peter J Schwartz

IRCCS Istituto Auxologico Italiano, Milan (Italy)

3 More presentations in this session

Presentation thumbnail
Interpretation of variants of unknown significance
Professor C. Bezzina (Amsterdam, NL)
Slides Video
Presentation thumbnail
Management of the catecholaminergic polymorphic ventricular tachycardia patient not protected by beta blockers
Doctor I. Denjoy (Paris, FR)
Slides Video
Presentation thumbnail
Risk stratification in Brugada syndrome
Professor S. Viskin (Tel Aviv, IL)
Slides Video

Access the full session

Session thumbnail
Implication of basic insights for management of channelopathies

The Event

Event poster

EHRA 2018

19 March 2018 11:45 CET
You may be interested in
thumbnail
Congress Presentation
Arrhythmias: management of patients with long QT
31 August 2024
thumbnail
Congress Session
Cardiogenetics in everyday practice
23 June 2023
thumbnail
Congress Presentation
Systematic Evaluation of KCNQ1 variant using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1
28 August 2020
thumbnail
Congress Presentation
Is mexiletine ready for prime time in patients with Type 2 Long QT Syndrome?
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources